3 issues to watch in biopharma in 2026 Prepare for some twists and turns when it comes to drugmakers

https://www.statnews.com/pharmalot/2026/01/05/biopharma-2026-issues-to-watch-obesity-pills-patent-reform-340b-drugs/ By Ed Silverman and Elaine ChenJan. 5, 2026